General form of registration statement for all companies including face-amount certificate companies

Stockholders' Equity (Details Narrative) (10-K)

v3.20.2
Stockholders' Equity (Details Narrative) (10-K) - USD ($)
 2 Months Ended 12 Months Ended
Sep. 30, 2019
May 25, 2018
Jun. 29, 2018
Dec. 31, 2019
Mar. 31, 2020
Aug. 31, 2019
Dec. 31, 2018
Preferred stock, shares authorized       1,000,000   10,000,000  
Common stock, shares authorized       100,000,000 100,000,000 350,000,000 350,000,000
Debt conversion price per share       $ 14.28 $ 14.28    
PoC Capital, LLC [Member]              
Number of common stock issued   113,280          
Warrants to purchase common stock   113,280          
Number of common stock, forfeited 56,640            
Warrants to purchase common stock, forfeited 56,640            
Purchase price per unit   $ 15.89          
Warrant exercise price per share   $ 19.07          
Amount paid to placement agent   $ 108,000          
Issued placement agent warrants to purchase shares   6,797          
Warrant term   3 years          
Transaction costs incurred   $ 60,457          
Clinical trial funding commitment $ 900,000 $ 1,800,000          
2018 Private Placement Transactions [Member]              
Number of units sold     200,369        
Purchase price per unit     $ 15.89        
Gross proceeds from unit sold     $ 3,200,000        
Warrant exercise price per share     $ 19.07        
Amount paid to placement agent     $ 167,526        
Issued placement agent warrants to purchase shares     12,021        
Warrant term     3 years        
Transaction costs incurred     $ 141,304        
Sale of stock price per share       $ 17.50      
Number of common stock to be issued       28,971      
Number of common stock to be issued, value       $ 506,993      
Pledge Agreement with PoC [Member]              
Number of common stock, pledged   56,640          
Warrants to purchase common stock, pledged   56,640          
Clinical trial funding commitment $ 1,800,000